SEELOS THERAPEUTICS, INC.·4

Mar 31, 5:10 PM ET

Mehra Raj 4

4 · SEELOS THERAPEUTICS, INC. · Filed Mar 31, 2023

Insider Transaction Report

Form 4
Period: 2023-03-30
Mehra Raj
DirectorSee Remarks10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-30+1,682,3001,682,300 total
    Exercise: $0.69Exp: 2033-03-30Common Stock (1,682,300 underlying)
  • Award

    Stock Option (right to buy)

    2023-03-30+200,000200,000 total
    Exercise: $0.69From: 2023-03-30Exp: 2033-03-30Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]1/4th of the shares subject to the option shall vest on March 30, 2024, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.
  • [F2]The Reporting Person voluntarily elected to be paid 36% of his 2022 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.

Documents

1 file
  • 4
    tm2311208-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT